Gene · 60489
Papers3,812
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,812
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A look back at the Virology Departmental Days of the Institut Pasteur (Le Touquet, May 13-15, 2024). | J Mol Cell Biol | 2025 | 39870374 | PubTator, text mining | PubMed |
| APOBEC-1 cofactors regulate APOBEC3-induced mutations in hepatitis B virus. | J Virol | 2025 | 39868801 | PubTator, text mining | PubMed |
| Ethanol Disrupts the Protective Crosstalk Between Macrophages and HBV-Infected Hepatocytes. | Biomolecules | 2025 | 39858451 | PubTator, text mining | PubMed |
| The unique structure of the highly conserved PPLP region in HIV-1 Vif is critical for the formation of APOBEC3 recognition interfaces. | mBio | 2025 | 39835817 | PubTator, text mining | PubMed |
| Human microRNA miR-197-3p positively regulates HIV-1 virion infectivity through its target DDX52 by stabilizing Vif protein expression. | J Biol Chem | 2025 | 39826696 | PubTator, text mining | PubMed |
| Erratum for Ara et al., "Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G". | J Virol | 2025 | 39817775 | PubTator, text mining | PubMed |
| Peptide design to control protein-protein interactions. | Chem Soc Rev | 2025 | 39817557 | PubTator, text mining | PubMed |
| Variability in HIV-1 transmitted/founder virus susceptibility to combined APOBEC3F and APOBEC3G host restriction. | J Virol | 2025 | 39714157 | PubTator, text mining | PubMed |
| Validation of the APOBEC3A-Mediated RNA Single Base Substitution Signature and Proposal of Novel APOBEC1, APOBEC3B, and APOBEC3G RNA Signatures. | J Mol Biol | 2024 | 39510348 | PubTator, text mining | PubMed |
| Structure-based prediction of protein-nucleic acid binding using graph neural networks. | Biophys Rev | 2024 | 39345796 | PubTator, text mining | PubMed |
| Physics-driven unsupervised deep learning network for programmable metasurface-based beamforming. | iScience | 2024 | 39246440 | PubTator, text mining | PubMed |
| Interactions between HIV proteins and host restriction factors: implications for potential therapeutic intervention in HIV infection. | Front Immunol | 2024 | 39221250 | PubTator, text mining | PubMed |
| Conformational Space Profiling Enhances Generic Molecular Representation for AI-Powered Ligand-Based Drug Discovery. | Adv Sci (Weinh) | 2024 | 39206753 | PubTator, text mining | PubMed |
| Highly homologous simian T-cell leukemia virus type 1 genome in Japanese macaques: a large cohort study. | Virol J | 2024 | 39080643 | PubTator, text mining | PubMed |
| Potential Role of APOBEC3 Family Proteins in SARS-CoV-2 Replication. | Viruses | 2024 | 39066304 | PubTator, text mining | PubMed |
| APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution. | Heliyon | 2024 | 38868014 | PubTator, text mining | PubMed |
| Prevalence of HBsAg among Moroccan HIV-1 infected patients and APOBEC3G variant frequencies in HIV-1/HBV co-infection. | J Infect Dev Ctries | 2024 | 38865405 | PubTator, text mining | PubMed |
| The Disassociation of A3G-Related HIV-1 cDNA G-to-A Hypermutation to Viral Infectivity. | Viruses | 2024 | 38793610 | PubTator, text mining | PubMed |
| Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line. | Sci Rep | 2024 | 38783078 | PubTator, text mining | PubMed |
| RNA editing in host lncRNAs as potential modulator in SARS-CoV-2 variants-host immune response dynamics. | iScience | 2024 | 38770134 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60489/papers?page=5